1st announcement an call for papers!

Download PDF
CLINAM 9 / 2016 Conference and Exhibition
European & Global Summit for Cutting-Edge Medicine
June 26 – 29, 2016 • Basel, Switzerland

The Conference at a Glance

In the previous eight years, the CLINAM Summit grew to the largest in its field with 12 presenting Noble Laureates and more than 500 participants from academia, industry, regulatory authorities and policy from over 40 different countries in Europe and worldwide. With this success and broad support by well beyond 20 renowned collaborating initiatives, the CLINAM-Summit is today one of the most important marketplaces for scientific exchange and discussions of regulatory, political and ethical aspects in this field of cutting edge medicine.

In particular, the CLINAM Summit emerged as exquisite forum for translation from bench to bedside, for European and international networking, and for industrial collaboration between companies, with academia, and point-of-contact with customers. The summit is presently the only place to meet the regulatory authorities from all continents to debate the needs of all stakeholders in the field with the legislators.

CLINAM 9/2016 continues with its successful tradition to cover the manifold interdisciplinary fields of Clinical and Targeted Nanomedicine in major and neglected diseases. As special focus area, CLINAM 09/2016 adds translation and enabling technologies, including, for example, cutting-edge molecular profiling, nano-scale analytics, single cell analysis, stem cell technologies, tissue engineering, in and ex vivo systems as well as in vitro substitute systems for efficacy and toxicity testing.

CLINAM 09/2016 covers the entire interdisciplinary spectrum of Nanomedicine and Targeted Medicine from new materials with potential medical applications and enabling technologies over diagnostic and therapeutic translation to clinical applications in infectious, inflammatory and neurodegenerative diseases, as well as diabetes, cancer and regenerative medicine to societal implications, strategical issues, and regulatory affairs. The conference is sub-divided into four different tracks running in parallel and provides ample possibilities for exhibitors as indicated by steadily increasing requests:

The Tracks and Topics of the Conference

TRACK 1: Clinical and Targeted Nanomedicine – Basic Research • Disease Mechanisms and Personalized Medicine • Regenerative Medicine • Novel Therapeutic and Diagnostic Approaches • Active and Passive Targeting • Targeted Delivery (antibodies, affibodies, aptamers, nano drug delivery devices) • Accurin Technology •Nano-Toxicology

TRACK 2: Clinical and Targeted Nanomedicine: Translation • Unsolved Medical Problems• Personalized Medicine and Theranostic Approaches • Regenerative Medicine • Advanced Breaking and Ongoing Clinical Trials • Applied Nanomedical Diagnostics and Therapeutics

TRACK 3: Enabling Technologies• Nanomaterial Analytics and Testing • Molecular Profiling for Research and Efficacy/Toxicology Testing (Genomics, Proteomics, Glycomics, Lipidomics, Metabolomics) • Functional Testing Assays and Platforms• Single Cell Analyses • Cell Tracking • Stem Cell Biology and Engineering Technologies • Microfluidics • Tissue Engineering – Tissues-on-a-Chip – Bioprinting •In vivo Testing •Novel Imaging Approaches • Medical Devices Track 4: Regulatory, Societal Affairs and Networking • Regulatory Issues in Nanomedicine • Strategy and Policy • The Patients` Perspective • Ethical Issues in Nanomedicine • University Village • Cutting-Edge EU-Project Presentations • Networking for International Consortium Formation

Dear colleagues, welcome to ENM2015 Meeting in Grenoble!

The French Society for Nanomedicine, together with the british society for nanomedicine, the dutsch society for nanomedicine, the german nanomedicine platform, and the European Nanomedicine platform organise the Nanomed Europe meeting this year in France, december 7-9th.

The themes are surely of great interests for you:
• Nanomedicine and cancer
• Nanomedicines for imaging, as devices or for regenerative medicine
What nanomedicine can do for macromolecules delivery and toxicity issues will be part of the sessions.

Great speakers have accepted to join the conference, they are both coming from academia and private companies and will attend roundtable discussions:
Arwyn Jones, Muthiah Manoharan (Alnylam), Charlie Gosse, Bruno Le Pioufle, Andrew Owen, Peter Wick, Hisataka Kobayashi (USA), Eric Vibert, Elias Fatal, François Berger, Marianne Ahsford (Astra Zeneca), Nicolas Grenier, Twan Lammers, Pierre-Yves Benhamou, Pierre Nassoy

For more detailed informations, please check our website, click here

Obviously, all conferences will be in english !
Do not hesitate to transfer the informations to students and colleagues who might be interested and send your abstract before september 30th!

Do you have an ambitious nanobiomedicine project? Apply and benefit from high level experts support!

ENATRANS launches the first Translation Advisory Board (TAB), a new instrument to provide free of charge advice and support to ambitious international nanomedicine projects.

The call is open to companies, academics and private researchers in Europe promoting nanomedicine projects. First-in-class recognized experts from industry will deliver concrete and invaluable advice to drive selected nanomedicine projects into innovative products for healthcare. Among those ambitious projects, the most promising will benefit from further high value services such as in-depth advice, showcase and coaching…  (Download the Flyer)

The applicants must have very promising nanomedicine projects, targeting unmet medical need for patients.

Applications received till September 14, 2015 may be eligible for the first TAB-in session, which will gather selected projects in a first phase of the service to be organised in Dublin, October 14, 2015.

APPLY HERE
Who are the experts?

Paul Smit – former senior position at Philips Healthcare, Mike Eaton – former senior positions at Celltech & UCB, David Bott – former senior position at BP, Ruediger Iden – former senior position at BASF, Eckhard Schwenner – former position at Bayer, Eric Mayes – CEO at Endomag, Laurent Levy – CEO at Nanobiotix

NanoMed North was one of the exhibitors at last week’s NanoForum in Stockholm. NanoForum is arranged by SwedNanoTech which is a nanotechnology network for both academia and industry in Sweden.

The “godfather” of nanotechnology; Eric Drexler was one of the keynote speakers and he gave a fascinating talk about advanced productive nanosystems. These nanosystems (nanoscale machinery) will according to Drexler have a large impact on for example life science industry in the future. If you want to know more about Eric Drexler´s work go to e-drexler.com.
“The Nanotechnology company of the year – award” was presented at NanoForum. The award is handed out to a young, innovative Swedish nanotechnology company. This year’s nominees were: Cline Scientific, Exeger, Insplorin, Nanexa and Promimic. The award went to Exeger for their Dye-sensitized solar cells.

We had a lot of visitors at the NanoMed North stand and we give a warm welcome to our new members that signed up at NanoForum.

Hanna Toftevall from GeccoDots. One of NanoMed North’s new members. GeccoDots is a nanotechnology company that work with multimodal contrast agents and biomarkers for medical imaging.

Niklas Holmquist, vice president of Cline Scientific, one of the nominated companies for the “Nanotechnology company of the year – award”. Cline Scientific are providing gradient surface technology to life science applications.